dual Pratiti majčinska vancomycin for c diff Jezero Taupo Imenovati Otuđiti
Update on the Management of Clostridium difficile Infection
Update on the Management of Clostridium difficile Infection
Update on Treatment of Clostridioides difficile Infection - Mayo Clinic Proceedings
Vancomycin-Resistant Enterococcus & Recurrent C diff Infection
FAQs for Clinicians about C. diff | CDC
Clostridium difficile Infection | NEJM
Antibiotic choice impacts C. difficile shedding and hospital contamination, study finds
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial - The Lancet Infectious Diseases
What's the “Diff” with C. Diff? A Management Update – CriticalCareNow
Management of Recurrent Clostridium difficile Infection: A Case-Based Approach | Consultant360
CDI
Breakthroughs in the treatment and prevention of Clostridium difficile infection | Nature Reviews Gastroenterology & Hepatology
Updates in the Management of Clostridium difficile for Adults
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial - The Lancet Infectious Diseases
Vancomycin Hydrochloride for Oral Solution USP Rx only
ACG publishes guidelines for preferred treatment of C. difficile infection
Treating and Preventing Clostridium difficile Infection in Long-Term Care Facilities
SciELO - Brasil - Recent changes in Clostridium difficile infection Recent changes in Clostridium difficile infection
Table 2 from Overview of severe Clostridium difficile infection. | Semantic Scholar
Recurrent Clostridioides difficile infection: Recognition, management, prevention | Cleveland Clinic Journal of Medicine
Treatment for C. difficile infection | Download Table